Although, TrkC‐miR2‐5p‐GC was relatively expressed at low level in most of the examined brain cancer biopsies, the highest expression level of it was detected in glioma biopsies (Figure 3B,C) compared with meningioma transition type 1 tissue samples as the control. Here, NTRK3 is linked to glioma.